• Toddalia asiatica contains 22 core active ingredients that target multiple pathways involved in rheumatoid arthritis pathogenesis.
• Dihydrochelerythrine and 8-Methoxychelerythrine specifically bind to PLCG2 and MAPK8, respectively, revealing potential molecular targets.
• Bioinformatics and molecular dynamics simulations provide a robust approach to elucidate the multi-target mechanisms of traditional Chinese medicine.
• The study supports the traditional use of Toddalia asiatica for rheumatoid arthritis and offers a foundation for developing novel therapeutic agents.